Atara Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary

Atara Biotherapeutics

08/08/2023 23:01

* Atara Biotherapeutics Inc  ATRA.OQ  reported a quarterly
adjusted loss of 68 cents​​ per share for the quarter ended in
June. The mean expectation of nine analysts for the quarter was
for a loss of 67 cents per share.
    * Revenue fell 98.1% to $957.00 thousand from a year ago;
analysts
expected $3.77 million. 
    * Atara Biotherapeutics Inc's reported EPS for the quarter
was a
loss of 68 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.6%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Atara Biotherapeutics Inc shares had risen by 39.8% this
quarter and lost 31.4% so far this year.
    * The company reported a quarterly loss of $70.8 million.
    * Wall Street's median 12-month price target for Atara
Biotherapeutics Inc is $20.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 10:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.67          -0.68          Missed
 Mar. 31 2023      -0.39          -0.72          Missed
 Dec. 31 2022      -0.51          -0.72          Missed
 Sep. 30 2022      -0.78          -0.82          Missed